|
Volumn 44, Issue 6, 2001, Pages 1411-1415
|
Etanercept therapy in children with treatment-resistant uveitis
a a b b a a c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CYCLOSPORIN;
ETANERCEPT;
HYBRID PROTEIN;
METHOTREXATE;
STEROID;
TUMOR NECROSIS FACTOR;
ADHESION;
ANTERIOR EYE CHAMBER;
ARTICLE;
CHILD;
CHILD CARE;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INTRAOCULAR PRESSURE;
JUVENILE RHEUMATOID ARTHRITIS;
MALE;
PRIORITY JOURNAL;
REMISSION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UVEITIS;
VISUAL ACUITY;
ADMINISTRATION, TOPICAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, JUVENILE RHEUMATOID;
CHILD;
CHILD, PRESCHOOL;
CYCLOSPORINE;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOGLOBULIN G;
INJECTIONS, SUBCUTANEOUS;
MALE;
METHOTREXATE;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
UVEITIS, ANTERIOR;
VISION DISORDERS;
VISUAL ACUITY;
|
EID: 0034974633
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O Document Type: Article |
Times cited : (250)
|
References (20)
|